0001104659-21-047509.txt : 20210407 0001104659-21-047509.hdr.sgml : 20210407 20210407151659 ACCESSION NUMBER: 0001104659-21-047509 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210407 DATE AS OF CHANGE: 20210407 EFFECTIVENESS DATE: 20210407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DepYmed Inc. CENTRAL INDEX KEY: 0001851177 IRS NUMBER: 464931675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-394946 FILM NUMBER: 21811912 BUSINESS ADDRESS: STREET 1: 3 BIOSCIENCE PARK DRIVE CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: (631) 686-5802 MAIL ADDRESS: STREET 1: 3 BIOSCIENCE PARK DRIVE CITY: FARMINGDALE STATE: NY ZIP: 11735 D 1 primary_doc.xml X0708 D LIVE 0001851177 DepYmed Inc. 3 BIOSCIENCE PARK DRIVE FARMINGDALE NY NEW YORK 11735 (631) 686-5802 DELAWARE None None Corporation true Andreas G. Grill c/o DepYmed Inc. 3 Bioscience Park Drive Farmingdale NY NEW YORK 11735 Executive Officer Director Samuel G. Backenroth 700 Technology Drive Pittsburgh PA PENNSYLVANIA 15209 Director Peter Young 1 Bungtown Road Cold Spring Harbor NY NEW YORK 11724 Director Shankar Hariharan 3 Mike Lane Smithtown NY NEW YORK 11787 Director Steve Winick 3 Expressway Plaza Roslyn NY NEW YORK 11577 Director Leo Guthart 3 Expressway Plaza Roslyn NY NEW YORK 11577 Director Pharmaceuticals Decline to Disclose 06b false 2021-04-01 false true true false 0 More than five Associated Persons None Rainmaker Securities, LLC 132995 3131 NE 1ST AVENUE UNIT 3002 MIAMI FL FLORIDA 33137 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA ME MAINE MD MARYLAND MI MICHIGAN MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA TX TEXAS WA WASHINGTON WI WISCONSIN false Catalytic Life Sciences, Inc. None None None 580 WASHINGTON ST., APT. 1105 BOSTON MA MASSACHUSETTS 02111 All States false 15000000 5550000 9450000 Amount sold includes $550,000 attributable to the conversion of a Simple Agreement for Future Equity into Series A-4 Preferred Sock. false 3 0 true 0 true Amounts are indeterminate at this time. 0 true A portion of the proceeds will be used to pay salaries of executive officers. Amount is indeterminate at this time. false DepYmed Inc. /s/ Andreas G. Grill Andreas G. Grill President & Chief Executive Officer 2021-04-07